Warning letter
Advanced Cosmetic Research Laboratories Inc.: warning letter of Sep 26, 2022
FDA warning letter 635176 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 635176 |
|---|---|
| Company | Advanced Cosmetic Research Laboratories Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug |
| Issue date | Sep 26, 2022 |
| Posted date | Oct 25, 2022 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 201.128, 211.58, 330, 211.22(a) |
| Inspection city | Chatsworth |
| Inspection ZIP | 91311 |
| Inspection start date | Apr 21, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: